Provided by Tiger Trade Technology Pte. Ltd.

OraSure

2.83
-0.0200-0.70%
Post-market: 2.830.00000.00%16:19 EST
Volume:381.19K
Turnover:1.07M
Market Cap:203.01M
PE:-3.49
High:2.85
Open:2.80
Low:2.79
Close:2.85
52wk High:4.22
52wk Low:2.08
Shares:71.73M
Float Shares:69.48M
Volume Ratio:0.99
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8109
EPS(LYR):-0.2620
ROE:-15.30%
ROA:-8.80%
PB:0.56
PE(LYR):-10.80

Loading ...

OraSure Technologies Receives Health Canada License for OraQuick HIV Self-Test

Reuters
·
Feb 10

OraSure Technologies Inc. kündigt Veröffentlichung von Finanzergebnissen an

Reuters
·
Feb 10

Orasure Technologies Confirms Receipt Of Director Nominations From Altai Capital

Reuters
·
Jan 16

OraSure confirms receipt of director nominations from Altai Capital

TIPRANKS
·
Jan 16

OraSure Technologies: Confirmed That Altai Capital Nominated Two Candidates to Stand for Election to Co's Board at 2026 Annual Stockholders Meet

THOMSON REUTERS
·
Jan 16

OraSure Technologies Confirms Receipt of Director Nominations From Altai Capital

THOMSON REUTERS
·
Jan 16

BRIEF-Altai Capital Management Nominates Two Highly-Qualified Candidates For Election To Orasure Board Of Directors

Reuters
·
Jan 15

Altai Capital Nominates Two Directors in Push for Change at OraSure Technologies

Reuters
·
Jan 15

Altai Capital Management: Nominates John Bertrand and Rishi Bajaj for OraSure Board

THOMSON REUTERS
·
Jan 15

Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors

THOMSON REUTERS
·
Jan 15

BRIEF-Orasure Submits Ct/Ng Molecular Self-Test And Colli-Pee™ Urine Collection Device For FDA Review

Reuters
·
Jan 05

OraSure Submits CT/NG Self-Test and Colli-Pee Device for FDA Review

Reuters
·
Jan 05

OraSure Submits Ct/Ng Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review

THOMSON REUTERS
·
Jan 05

OraSure Issues Statement Regarding Altai’S Intent To Nominate Director Candidates

Reuters
·
Dec 18, 2025

OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates

THOMSON REUTERS
·
Dec 18, 2025

OraSure Technologies: Upon Receipt of Any Formal Director Nominations From Altai, Will Review Them & Present Board's Recommendations in Due Course

THOMSON REUTERS
·
Dec 18, 2025

OraSure Technologies Inc: Board Ultimately Determined Not to Appoint Rishi Bajaj to Serve as a Director

THOMSON REUTERS
·
Dec 18, 2025

BRIEF-Altai Capital to Nominate Two Candidates for OraSure Board

Reuters
·
Dec 17, 2025

Altai Capital Nominates Two Directors in Push for Change at OraSure Technologies

Reuters
·
Dec 17, 2025

Altai Capital: Owns 5.2% of OraSure Stock

THOMSON REUTERS
·
Dec 17, 2025